Clinical Trial Update: Dendritic Cells for Immunotherapy of Metastatic Endometrial Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on dendritic cell-based immunotherapy for metastatic endometrial cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• Dendritic cell-based immunotherapy

Snippet

Sponsor: Radboud University Medical Center | Conditions: Endometrial Cancer | Phase 2 | Status: COMPLETED